| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 8e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |